交叉截面证据对抗高血和高血对胆利酶活动的影响
Georgian medical news
|October 10, 2025
概括
胆酶水平,包括血胆酶 (BChE) 和红细胞乙胆酶 (AChE),随着2型糖尿病及其并发症的恶化而下降. 隔离性失脂症显示胆酶活性增加,表明潜在的低成本糖尿病生物标志物.
科学领域:
- 生物化学 生物化学
- 内分泌学 在内分泌学.
- 临床化学 临床化学
背景情况:
- 糖尿病的全球增长需要负担得起的生物标志物,而不仅仅是葡萄糖和HbA1c.
- 血乙基胆化酶 (BChE) 和红细胞乙基胆化酶 (AChE) 是潜在的生物标志物,因为它们与代谢障碍有关.
- 调查胆酶活性与糖尿病类型,控制,并发症和失脂症相关的研究至关重要.
研究的目的:
- 为了确定血BChE和红细胞AChE活动是否与糖尿病类型相关.
- 评估胆酶活性,血糖控制和糖尿病慢性并发症之间的关系.
- 为了评估与健康对照组相比,在患有隔离性脂质失调症的患者中胆酶活性.
主要方法:
- 这是一项涉及298名患有1型糖尿病,2型糖尿病 (单疗或联合疗法) 或孤立性脂质失调症的患者,以及30名健康对照者的横截研究.
- 血BChE和红细胞AChE活动使用电计测定法进行测量.
- 患者按血糖控制,并发症状况,治疗和并发症分层.
主要成果:
- 与对照组相比,在大多数2型糖尿病亚组中观察到明显较低的BCHE和ACHE活动.
- 控制不良的2型糖尿病和慢性并发症显示了酶水平的最大降低.
- 隔离性脂质失调与明显升高的BCHE和ACHE水平有关.
结论:
- 胆酶活性下降,特别是ACHE,与2型糖尿病中血糖控制较差和血管并发症相关.
- 胆酶水平升高与隔离性失脂症有关.
- 胆酶测定表明,作为糖尿病管理的成本效益高的辅助生物标志物,有希望,等待进一步验证.
更多相关视频
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
15.0K
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
717
相关概念视频
Cholinesterases: Distribution and Function
944
Cholinesterases are a group of serine hydrolase enzymes that play a crucial role in the breakdown of choline esters. The two primary types of cholinesterases are acetylcholinesterases (AChEs) and butyrylcholinesterase (BuChEs), which differ in their distribution, function, and substrate specificity. AChEs, also known as true cholinesterases, specifically hydrolyze acetylcholine, while BuChEs, often referred to as pseudocholinesterases, can hydrolyze various choline esters, including...
944
Indirect-Acting Cholinergic Agonists: Mechanism of Action
2.5K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
2.5K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
1.5K
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
1.5K
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K
Anticholinesterase Agents: Poisoning and Treatment
1.5K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
